These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8938519)

  • 1. Production of human natural killer cells for adoptive immunotherapy using a computer-controlled stirred-tank bioreactor.
    Pierson BA; Europa AF; Hu WS; Miller JS
    J Hematother; 1996 Oct; 5(5):475-83. PubMed ID: 8938519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor.
    Sutlu T; Stellan B; Gilljam M; Quezada HC; Nahi H; Gahrton G; Alici E
    Cytotherapy; 2010 Dec; 12(8):1044-55. PubMed ID: 20795758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy.
    Tam YK; Martinson JA; Doligosa K; Klingemann HG
    Cytotherapy; 2003; 5(3):259-72. PubMed ID: 12850795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and expansion of natural killer cells for NK cell-based immunotherapy.
    Becker PS; Suck G; Nowakowska P; Ullrich E; Seifried E; Bader P; Tonn T; Seidl C
    Cancer Immunol Immunother; 2016 Apr; 65(4):477-84. PubMed ID: 26810567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large scale ex vivo expansion and activation of human natural killer cells for autologous therapy.
    Miller JS; Klingsporn S; Lund J; Perry EH; Verfaillie C; McGlave P
    Bone Marrow Transplant; 1994 Oct; 14(4):555-62. PubMed ID: 7532064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale expansion of cytomegalovirus-specific cytotoxic T cells in suspension culture.
    Foster AE; Forrester K; Gottlieb DJ; Barton GW; Romagnoli JA; Bradstock KF
    Biotechnol Bioeng; 2004 Jan; 85(2):138-46. PubMed ID: 14704996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a clinical model for ex vivo expansion of multiple populations of effector cells for adoptive cellular therapy.
    Meehan KR; Wu J; Webber SM; Barber A; Szczepiorkowski ZM; Sentman C
    Cytotherapy; 2008; 10(1):30-7. PubMed ID: 18202972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem/stromal cells.
    Dos Santos F; Campbell A; Fernandes-Platzgummer A; Andrade PZ; Gimble JM; Wen Y; Boucher S; Vemuri MC; da Silva CL; Cabral JM
    Biotechnol Bioeng; 2014 Jun; 111(6):1116-27. PubMed ID: 24420557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92.
    Tonn T; Becker S; Esser R; Schwabe D; Seifried E
    J Hematother Stem Cell Res; 2001 Aug; 10(4):535-44. PubMed ID: 11522236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression.
    Decot V; Voillard L; Latger-Cannard V; Aissi-Rothé L; Perrier P; Stoltz JF; Bensoussan D
    Exp Hematol; 2010 May; 38(5):351-62. PubMed ID: 20172016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vitro expansion of human placenta-derived mesenchymal stem cells in stirred bioreactor.
    Yu Y; Li K; Bao C; Liu T; Jin Y; Ren H; Yun W
    Appl Biochem Biotechnol; 2009 Oct; 159(1):110-8. PubMed ID: 19266320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro suspension and bioreactor culture of hematopoietic cells].
    Chi ZY; Xia QM; Kang ZZ; Tan WS; Dai GC
    Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):587-92. PubMed ID: 15969089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy.
    Lim SA; Kim TJ; Lee JE; Sonn CH; Kim K; Kim J; Choi JG; Choi IK; Yun CO; Kim JH; Yee C; Kumar V; Lee KM
    Cancer Res; 2013 Apr; 73(8):2598-607. PubMed ID: 23580577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor.
    Rafiq QA; Brosnan KM; Coopman K; Nienow AW; Hewitt CJ
    Biotechnol Lett; 2013 Aug; 35(8):1233-45. PubMed ID: 23609232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo expansion of natural killer cells for clinical applications.
    Klingemann HG; Martinson J
    Cytotherapy; 2004; 6(1):15-22. PubMed ID: 14985163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstrating the Manufacture of Human CAR-T Cells in an Automated Stirred-Tank Bioreactor.
    Costariol E; Rotondi MC; Amini A; Hewitt CJ; Nienow AW; Heathman TRJ; Rafiq QA
    Biotechnol J; 2020 Sep; 15(9):e2000177. PubMed ID: 32592336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing the scalable manufacture of primary human T-cells in an automated stirred-tank bioreactor.
    Costariol E; Rotondi M; Amini A; Hewitt CJ; Nienow AW; Heathman TRJ; Micheletti M; Rafiq QA
    Biotechnol Bioeng; 2019 Oct; 116(10):2488-2502. PubMed ID: 31184370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical-Grade Manufacturing of Therapeutic Human Mesenchymal Stem/Stromal Cells in Microcarrier-Based Culture Systems.
    Fernandes-Platzgummer A; Carmelo JG; da Silva CL; Cabral JM
    Methods Mol Biol; 2016; 1416():375-88. PubMed ID: 27236684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid expansion in the WAVE bioreactor of clinical scale cells for tumor immunotherapy.
    Meng Y; Sun J; Hu T; Ma Y; Du T; Kong C; Zhang G; Yu T; Piao H
    Hum Vaccin Immunother; 2018; 14(10):2516-2526. PubMed ID: 29847223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.